Literature DB >> 16728431

Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.

Mohammad K Mohammad1, Michael Morran, Brandon Slotterbeck, Douglas W Leaman, Yaping Sun, Hermann von Grafenstein, Soon-Cheol Hong, Marcia F McInerney.   

Abstract

The expression, responsiveness and regulation of mouse Toll-like receptors (TLRs) in bone marrow-derived macrophages (BM-Ø) were investigated prior to and following the development of diabetes. Expression of TLR3 and TLR5 was significantly higher in newly diabetic non-obese diabetic (NOD) mice when compared with pre-diabetic and control strains of mice. The TLR3 ligand poly(I)poly(C) triggered up-regulation of its own receptor in NOR and pre-diabetic NOD, but TLR3 was already highly expressed in diabetic NOD mice. Expression levels of TLR3 correlated with poly(I)poly(C)-triggered IFN activity. LPS triggered down-regulation of TLR4 in pre-diabetic NOD, NOR and BALB/c, while levels of TLR4 remained consistently elevated in type 1 diabetic NOD and type 2 diabetic NZL mice. Dysregulation of TLR4 expression in the diabetic state correlated with increased nuclear factor kappa B (NF-kappaB) activation in response to the TLR4 ligand LPS and higher expression of IL-12p40, tumor necrosis factor alpha (TNFalpha), IL-6 and inducible nitric oxide synthase but lowered expression of IL-10. Exposure of bone marrow precursor cells from NOD mice to a hyperglycemic environment during differentiation into macrophages resulted in elevated levels of TLR2 and TLR4 and the cytokine TNFalpha. The results indicate that macrophage precursors are influenced by systemic changes in diabetes favoring altered TLR expression and sensitivity that may influence susceptibility to macrophage-mediated diabetes complications and explain inappropriate responses to infection in diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728431     DOI: 10.1093/intimm/dxl045

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  54 in total

1.  Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Authors:  Hideaki Yamasawa; Masayuki Nakayama; Masashi Bando; Yukihiko Sugiyama
Journal:  Inflamm Res       Date:  2012-01-07       Impact factor: 4.575

2.  The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications.

Authors:  Ishwarlal Jialal; Harmeet Kaur
Journal:  Curr Diab Rep       Date:  2012-02-08       Impact factor: 4.810

3.  Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice.

Authors:  S Bhattacharyya; I O-Sullivan; S Katyal; T Unterman; J K Tobacman
Journal:  Diabetologia       Date:  2011-10-20       Impact factor: 10.122

4.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

5.  Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.

Authors:  Sridevi Devaraj; Peter Tobias; Balakuntalam S Kasinath; Rajendra Ramsamooj; Alaa Afify; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-26       Impact factor: 8.311

6.  Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  J Biol Chem       Date:  2015-03-17       Impact factor: 5.157

7.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

8.  Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.

Authors:  Sridevi Devaraj; Ishwarlal Jialal
Journal:  Cytokine       Date:  2009-05-15       Impact factor: 3.861

Review 9.  Targeting Toll-like receptors for treatment of SLE.

Authors:  Christopher G Horton; Zi-jian Pan; A Darise Farris
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

10.  Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Authors:  Mohan R Dasu; Sridevi Devaraj; Samuel Park; Ishwarlal Jialal
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.